| Balance Sheet of AstraZeneca Pharma (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
| Total Share Capital |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
| Reserves and Surplus |
359.44 |
295.80 |
241.93 |
217.87 |
151.01 |
|
| Total Reserves and Surplus |
359.44 |
295.80 |
241.93 |
217.87 |
151.01 |
|
| Total Shareholders Funds |
364.44 |
300.80 |
246.93 |
222.87 |
156.01 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Deferred Tax Liabilities [Net] |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Other Long Term Liabilities |
9.30 |
0.00 |
0.00 |
0.00 |
1.27 |
|
| Long Term Provisions |
5.38 |
2.02 |
6.66 |
2.28 |
0.00 |
|
| Total Non-Current Liabilities |
14.68 |
2.02 |
6.66 |
2.28 |
1.27 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Trade Payables |
209.72 |
168.20 |
95.34 |
87.66 |
94.63 |
|
| Other Current Liabilities |
73.16 |
56.21 |
76.63 |
75.23 |
120.73 |
|
| Short Term Provisions |
44.36 |
34.57 |
34.98 |
27.45 |
33.08 |
|
| Total Current Liabilities |
327.24 |
258.98 |
206.95 |
190.34 |
248.44 |
|
| Total Capital And Liabilities |
706.36 |
561.80 |
460.54 |
415.49 |
405.72 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
71.53 |
74.83 |
75.46 |
86.84 |
97.36 |
|
| Intangible Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Capital Work-In-Progress |
24.24 |
6.90 |
3.57 |
4.81 |
6.31 |
|
| Other Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Fixed Assets |
95.77 |
81.73 |
79.03 |
91.65 |
103.67 |
|
| Non-Current Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Deferred Tax Assets [Net] |
14.64 |
23.36 |
32.55 |
40.22 |
0.00 |
|
| Long Term Loans And Advances |
3.90 |
2.86 |
2.64 |
2.87 |
33.16 |
|
| Other Non-Current Assets |
49.73 |
49.13 |
25.40 |
29.20 |
0.61 |
|
| Total Non-Current Assets |
164.04 |
157.08 |
139.62 |
163.94 |
137.44 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Inventories |
165.15 |
118.10 |
113.15 |
57.71 |
76.73 |
|
| Trade Receivables |
83.21 |
79.75 |
54.63 |
43.00 |
84.36 |
|
| Cash And Cash Equivalents |
252.52 |
173.30 |
125.92 |
115.58 |
76.83 |
|
| Short Term Loans And Advances |
0.80 |
0.81 |
1.24 |
1.22 |
27.64 |
|
| OtherCurrentAssets |
40.64 |
32.76 |
25.98 |
34.04 |
2.73 |
|
| Total Current Assets |
542.32 |
404.72 |
320.92 |
251.55 |
268.28 |
|
| Total Assets |
706.36 |
561.80 |
460.54 |
415.49 |
405.72 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
69.19 |
32.57 |
11.85 |
17.25 |
42.75 |
|
| CIF VALUE OF IMPORTS |
|
|
|
|
|
|
| Raw Materials |
0.00 |
0.00 |
0.00 |
0.00 |
16.20 |
|
| Stores, Spares And Loose Tools |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Trade/Other Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Capital Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.15 |
|
| EXPENDITURE IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| Expenditure In Foreign Currency |
308.00 |
196.33 |
201.49 |
0.00 |
4.15 |
|
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS |
|
|
|
|
|
|
| Dividend Remittance In Foreign Currency |
-- |
-- |
-- |
-- |
-- |
|
| EARNINGS IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| FOB Value Of Goods |
-- |
-- |
-- |
-- |
-- |
|
| Other Earnings |
30.50 |
23.62 |
29.96 |
-- |
9.70 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
2.50 |
2.50 |
2.50 |
2.50 |
2.50 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
0.01 |
|
| Non-Current Investments Unquoted Book Value |
-- |
-- |
-- |
-- |
-- |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Current Investments Unquoted Book Value |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
